Podocytes are critical components of the nephron filtration barrier and are depleted in many kidney injuries and disease states. Terminally differentiated adult podocytes are highly specialized, postmitotic cells, raising the question of whether the body has any ability to regenerate lost podocytes. This timely question has recently been illuminated by a series of innovative studies. Here, we review recent progress on this topic of significant interest and debate.
INTRODUCTION: PODOCYTE REGENERATION IN THE ADULT KIDNEY
The current review is intended to provide a balanced view on the broad topic of adult podocyte regeneration. Podocyte differentiation and regeneration during kidney development is well discussed by others [1, 2] . For context, nephron progenitor cells (NPCs), which give rise to the proximal nephron including podocytes during kidney embryogenesis, cease to exist in mammalian kidneys shortly after birth [3, 4] . NPCs, also known as metanephric mesenchyme cells, express SIX2 and CITED1 and self-renew only during kidney development [3, 4] .
We will use the dictionary definition of regeneration (biology), which is 'the ability to recreate lost or damaged tissues, organs and limbs'. We would argue therefore, in states in which the kidney and/or adult podocytes are damaged, that a simple requirement for podocyte regeneration is an actual decrease in the number of podocytes. Stated differently, we do not expect podocyte regeneration in diseases in which podocyte number has not been reduced.
ABSOLUTE AND RELATIVE PODOCYTE NUMBER
This principle segues to the notion of absolute podocyte number versus relative podocyte number [5,6 & ,7] . The latter, also known as podocyte density, is simply a measure of absolute podocyte number divided by the glomerular volume it occupies. The denominator, glomerular volume, is influenced by age, nephron number, obesity and other factors [8] . A decrease in podocyte number or density below a certain threshold has clearly been shown to underlie the onset of proteinuria and the development of glomerulosclerosis [9] . Moreover, the lower the podocyte number/density, the more severe the glomerular scarring [9, 10] .
RELATIVE PODOCYTE NUMBER DEPLETION
If the glomerular volume increases without any change in absolute podocyte number, podocyte density will decrease [25] . This occurs following nephrectomy, in the transplanted kidney, in aging, obesity and certain glomerular diseases following the scarring of injured glomeruli [8] . The increased glomerular volume leads to a mismatch in coverage by podocytes of underlying glomerular capillaries [8] . This is initially compensated for by hypertrophy of podocytes (i.e. an increase in their size without an increase in their number), that over time becomes paradoxically maladaptive [8] . Under these circumstances, podocyte density is reduced, but podocyte number does not change. Whether this is sufficient to trigger podocyte regeneration is not yet clear.
EVIDENCE THAT ADULT PODOCYTES CAN BE PARTIALLY OR FULLY REPLACED IN DISEASE STATES
Several lines of evidence support the notion that adult podocytes can be replaced following their depletion. These include the following:
(1) An increase in podocyte number in disease using cellspecific markers: In studies using nongenetic cell fate mapping, the identification of podocytes relies on several markers such as WT-1 [26] , p57 [23] and others [27] . Several studies have shown in experimental models of diabetic and nondiabetic kidney disease that podocyte number could be raised/increased when animals were given ACE-I, ARBs, steroids, retinoids or normalization of their diabetic state [28-31,32 && ,33] . In all these studies, the increase in podocyte number occurred in the absence of podocyte proliferation. Changes in podocyte-specific proteins can result secondary to injury, and thus the specificity of these changes also needs to be considered. (2) An increase in podocyte number in disease using genetic labeling techniques: Inducible conditional reporters enable labeling of podocytes for lineage tracing. For example, the mT/mG mouse crossed with a podocin-rtTA mouse permanently labels all cells in the body with a red color. When Cre is turned on by activating the podocin promoter with doxycycline, all podocytes become green in color, whereas other cells remain red [34, 35] . Wanner et al. [36 && ] used mT/mG mice crossed with inducible diphtheria toxin receptor (DTR) mice to partially deplete podocytes with the diphtheria toxin. Podocytes were labeled green and expressed DTR following doxycycline administration; when diphtheria toxin was subsequently administered, there was a decrease in green cells (podocytes). When followed over 4 weeks, red cells appeared on the glomerular tuft and expressed podocyte KEY POINTS Adult podocytes are unable to self-renew as they are unable to proliferate.
Replacement of adult podocytes that have been lost in disease needs to derive from stem/progenitor cells.
Glomerular parietal epithelial cells and cells of renin lineage are two local sources of adult podocyte stem/ progenitor cells.
To prevent/limit and even reverse glomerular scarring due to podocyte loss, the goal for replacement does not need to be 100%.
proteins. The authors of the manuscript concluded that overall their results suggest a podocyte renewal of 38% of ablated cells.
Using the same mT/mG mice, Lasagni et al.
[37 && ] depleted podocytes with the podocyte toxin Adriamycin. When followed over time, the percentage of newly generated podocytes was 6% when all podocytes were taken in to account or 30.4% in mice that had remission of their proteinuria. In cell fate mapping studies with a conditional paired box gene 2 (PAX2) -confetti mouse, marking parietal epithelial cells (PECs), indicated that PECs adopted podocyte characteristics and accounted for $25% replacement of depleted podocytes in mice with regression of proteinuria compared with those that did not. Overall, podocyte regeneration was further increased to 32.6% when the glycogen synthase inhibitor 3 (GSK3)-inhibitor BIO (6-Bromoindirubin-3'-oxome) was administered [37
Our group used an inducible podocin rtTA reporter, which permanently labels podocytes with ZsGreen only when mice are given doxycycline [38 & ]. The total complement of podocytes, measured by the podocyte markers p57, podocin and synaptopodin along with the podocyte reporter ZsGreen, was abruptly depleted by 30-40% with a cytopathic antipodocyte antibody. This coincided with similar decreases in podocyte labeling and DAPI (4',6-Diamidino-2-Phenylindole) staining. Importantly, following this nadir in podocytes, there was a subsequent increase in the number of cells staining for p57, podocin and synaptopodin as well as DAPI staining, but not ZsGreen. Repeated BrdU (5-Bromo-2'-deoxyuridine), administered to measure cumulative proliferation, was not detected in podocytes.
Finally, using live animal imaging, Hackl et al. [39] also showed that podocytes can be replaced in experimental models of glomerular disease. Serial multiphoton microscopy on the same injured glomerulus revealed the appearance of a new podocyte (labeled with a fluorescent reporter) within 24 h of the previous image, providing direct evidence for podocyte regeneration.
In summary, the studies above strongly support the notion that following a decrease in absolute podocyte number in experimental mouse models, podocytes can be at least partially replaced from a nonpodocyte source.
ADULT PODOCYTE PROGENITORS
Based on the preceding literature, we recommend that the following criteria be considered as evidence that a stem/progenitor cell can transdifferentiate to an adult podocyte fate:
(1) migration from their original location to a new location along the glomerular basement membrane (GBM) in the glomerular tuft (2) de novo expression of several podocyte proteins, coincident with loss of their original cell-specific proteins (3) expression of epithelial cell markers (4) acquisition of classic podocyte ultrastructural features (such as foot process and slit diaphragms) (5) displaying functionality (such as the production of vascular endothelial growth factor and specific extracellular matrix proteins, angiotensin II responsiveness and limiting albumin permeability).
We also recommend a context for the need for podocytes to be replaced and for their progenitors to therefore be called upon, that is a decrease in absolute podocyte number.
Having argued that adult podocytes can be replaced either partially or fully by stem/progenitor cells and that this number can be significantly increased under certain conditions such as renin angiotensin aldosterone system (RAAS) blockade [32 && ] and GSK3 inhibition [37 && ], important questions arise including what are the sources for podocyte replacement, what is the evidence in support of this, and is replacement the cumulative response from more than one source in a podocyte depleted glomerulus? Although it is tempting to speculate on opportunities for podocyte replacement from organoids [40, 41] and sources such as the bone marrow and amniotic fluid [42] , we will address what is reported regarding two potential endogenous sources normally resident in the kidney.
Glomerular parietal epithelial cells as adult podocyte progenitors
Several lines of evidence support the rationale that PECs possess biological programs necessary to differentiate into adult podocytes. First, PECs and podocytes arise from a common restricted pool of mesenchymal cells during glomerulogenesis [43] . Second, a PEC subpopulation defined as cells at the tubular pole coexpressing the stemness markers CD133 and CD24 has been identified [44] . Third, a subpopulation of PECs lining Bowman's capsule typically at the glomerular vascular pole coexpress both PEC and podocyte proteins and even show ultrastructural features of podocytes [45] . These cells have been named 'glomerular epithelial transitional cells'. When such cells along Bowman's capsule only express podocyte proteins under normal conditions, they have been referred to as 'ectopic podocytes' [46] , and when they express WT-1, typical of adult podocytes [26] , they have been called 'parietal podocytes' [46] . Moreover, the number and density of glomerular epithelial transitional cells increases under certain experimental and human glomerular diseases, oftentimes accompanying podocyte depletion, such as diabetic kidney disease [29] , aging nephropathy [47] , focal segmental glomerulosclerosis (FSGS) [48] and membranous nephropathy [31] . In addition, the number of transition cells can be increased by administration of retinoids [31] , corticosteroids [49] and angiotensin-converting enzyme inhibitor (ACE inhibition) [30] , as well as an improvement in the diabetic milieu [29] .
However, we need to be cautious in these interpretations, because we [38 & ] and others [39, 50] have reported that podocytes can migrate from the glomerular tuft to Bowman's capsule, where they might begin to coexpress PEC proteins. Thus, we will discuss data supporting and not supporting PECs as adult podocyte progenitors. [12] .
Studies supporting a role for parietal epithelial cells as adult podocyte progenitors
Using normal human kidneys, Romagnani's laboratory isolated cells from Bowman's capsule coexpressing PEC proteins and the surface markers CD133/CD24 and then propagated them ex vivo in a cell culture system [44] , which required a decrease in Notch signaling [53] . These 'renal progenitor cells' could be expanded under certain cell culture conditions and began to coexpress markers of podocytes and tubular cells [54, 55] . Similarly, blockade of the chemokine stromal-derived factor (SFD/CXCL12) enhanced the differentiation of renal progenitors toward a podocyte phenotype in culture [56] . Furthermore, when administered intravenously to SCID mice with Adriamycin-induced nephropathy, renal progenitors were found in the glomerulus, expressing podocyte proteins, acquiring ultrastructural features of podocytes and were accompanied by improved disease outcomes [44] .
Several studies have highlighted factors that inhibit PEC progenitors. Peirid showed that the subpopulation of PECs expressing CD133/CD24 require retinoids for normal survival and function [57] . Moreover, when albumin was taken up by PECs [58] , endogenous retinoid synthesis was impaired [57] . This might explain in part why podocyte regeneration is limited in albuminuric states. Benigni et al. [59] recently showed that a subpopulation of PECs coexpressing the differentiation marker neural cell adhesion molecule also express the angiotensin 1 receptor and that proliferation of these cells could be reduced by giving rats the angiotensin-converting enzyme inhibitor (ACE inhibitor) Lisinopril [59, 60] . Anders' laboratory showed that a-interferons and b-interferons reduced the capacity of PEC progenitors to induce nephrin mRNA expression [61] .
We have reported that abrupt podocyte depletion induced by the administration of a cytotoxic antipodocyte antibody is followed by partial podocyte replacement, in the absence of podocyte proliferation, and that RAAS inhibitors can further augment podocyte replacement [30,32
To determine if neighboring PECs might serve this role, podocytes were depleted in PEC-reverse tetracycline-transactivator/LC1/Rosa26 reporter ( pPECrtTA/LC1/R26R) mice [62, 63] . A subset of labeled PECs migrated from Bowman's capsule onto the glomerular tuft, where they de novo began to express several proteins considered podocyte-specific (Fig. 1) 
Studies lacking a supporting a role for parietal epithelial cells as adult podocyte progenitors
An important recent article showed that in humans, podocyte number increased during adolescence by up to 20% [12] . This suggested a pool of nonpodocyte cells that served a progenitor role, as podocytes cannot adequately proliferate beyond glomerulogenesis. Using a transgenic mouse model to specifically label PECs permanently in vivo, Appel et al. [62] showed that a subset of PECs migrate to the glomerular tuft during mouse adolescence, where they begin to express podocyte proteins and also take on their ultrastructural shape. However, these authors have concluded in subsequent studies [51 & ] that PECs do not serve as podocyte progenitors in adult mice in disease, a notion recently supported by Huber's laboratory [36 && ]. Although these studies were robustly performed, the three models studied, namely uninephrectomy, 5/6 nephrectomy and early middle-aged mice 12 months of age, are typically not accompanied by a decrease in absolute podocyte number but rather podocyte density, due to an increase in glomerular volume. Additional studies in models of absolute podocyte number depletion are therefore required.
In several states of podocyte depletion, the number of glomerular epithelial transition cells (defined as cells coexpressing PEC and podocyte proteins) is increased both along Bowman's capsule and in the glomerular tuft [47, 65] . Guhr et al. [66] showed that the de novo expression of podocyte proteins in PECs was due to reduced ubiquitin-mediated degradation. Studies using reporter mice have suggested a very different paradigm. Following injury, a subset of labeled podocytes could be detected having moved from the glomerular tuft and now lining Bowman's capsule [38 & ,39,50,52,67]. In some instances, the labeled podocytes coexpressed PEC proteins in addition to podocyte proteins. This podocyte-to-PEC migration may occur in response to injury or loss of PECs [68] . Thus, cells coexpressing PEC and podocyte proteins along Bowman's capsule could derive from migrating podocytes.
Taken together, there are compelling data that support a biological role for PECs as adolescent and adult podocyte progenitors. Yet, there is no consistency across all the models and marker systems (Table 1) . We need to consider several variables that might explain these differences such as species and experimental diseases studied. Although a PEC might well differentiate into an adult podocyte, the magnitude of 'regeneration' that results from this alone may be inadequate to fully replace the number of podocytes depleted, and the precise cues and mechanisms underlying such events are not yet well delineated. There may well be bidirectional repair/regenerative process ongoing, in which PECs differentiate into podocytes and podocytes differentiate into PECs. Also, we must be cautious in that the animal models of PEC fate mapping have not been fully reproduced in independent studies and that use of temporally expressed markers in tissue sections is not a surrogate for fate mapping.
Cells of renin lineage as adult podocyte progenitors
Cells of renin lineage (CoRL) are vascular smooth muscle cells that produce, or once produced, renin [69] . Under normal conditions, they are restricted to the juxtaglomerular compartment (JGC) in adults and comprise approximately 0.01% of the total kidney cell number. They derive from FoxD1-positive stromal cells [70] . Total CoRL number decreases in aged mice [71] . CoRL can transdifferentiate into smooth muscle cells, mesangial cells and possibly pericytes [72, 73] . When VHL is selectively deleted in CoRL, they can differentiate into erythropoietin-producing cells [74] . CoRL can transdifferentiate into adult mesangial cells in glomerular disease [75] and contribute to the interstitial pericyte pool following ureteral obstruction [76] . Adult CoRL themselves can be regenerated by adult renal mesenchymal-like cells that express CD44, c-Kit and/or CD105 [77] . Adult CoRL are therefore multipotent with marked stemness, serving as progenitors for several kidney cell types and can themselves be replaced by progenitors as well.
Studies supporting a role for cells of renin lineage as adult podocyte progenitors
To determine whether CoRL also can serve as progenitors for podocytes, we utilized several constitutive and inducible reporter mice that permanently tag renin-producing cells using Cre/loxP somatic DNA recombination [78] . Administering tamoxifen-labeled CoRL only in Ren1c-CreER, tdTomatoR animals and labeled cells were confined to the JGC. Over 95% of labeled cells coexpressed renin, and none was detected in glomeruli of normal mice, as expected [32 && ,78] . We depleted podocyte number by 30-40% in reporter mice using a model of classic FSGS induced by cytotoxic antipodocyte antibodies [32 && ,78] . Several lines of evidence support a paradigm of CoRL serving as adult podocyte stem/progenitors.
First, labeled CoRL were detected in a subpopulation of injured glomeruli (Fig. 2) . In the majority of glomeruli containing labeled CoRL, cells in the glomerulus were distributed either within the glomerular tuft adherent to the GBM or along Bowman's capsule. Neither renin protein nor renin mRNA was detected in glomeruli of FSGS mice. In mice that were not exposed to tamoxifen, no cells were detected either in the JGC or intraglomerular compartments [78] . The degree of scarring within individual glomeruli was also significantly lower in glomeruli that contained labeled CoRL.
Second, a subpopulation of intraglomerular CoRL coexpressed one of the following podocyte proteins: WT-1, nephrin, podocin or synaptopodin [32 && ,78] . CoRL did not express nephrin, podocin or synaptopodin when in a JGC. Some mapped CoRL cells that had moved into diseased glomeruli did not coexpress markers of podocytes.
Third, when CoRL reporter mice were given either the ACE-inhibitor Enalapril or the AT1 blocker Losartan in the absence of disease, the pool of CoRL increased in the JGC, due to both recruitment and proliferation of existing CoRL; a subset of labeled CoRL migrated to the glomerulus prior to podocyte depletion; and the number of CoRL that migrated to the glomerulus from the JGC following podocyte depletion was significantly augmented [32 && ]. The latter was accompanied by overall kidney function improvement and a higher podocyte number.
Fourth, we next asked if these events also occur following progressive podocyte depletion (rather than abrupt loss) in two additional models (5/6 nephrectomy and aged kidney). First, a 5/6 nephrectomy remnant kidney model was induced Human kidney A subpopulation of PECs at tubular pole costains for the stem/progenitor markers CD133/CD24 [53] When these cells are isolated, and grown ex vivo, they have self-renewal potential and high cloning efficiency [44] Under certain culture conditions, they acquire podocyte phenotypic features [55] Cells harvested from normal kidneys that double-labeled for PEC and stem/progenitor markers improved disease outcomes when injected into mice with experimental FSGS Studies suggesting, but not definitively proving, that a subset of PECs are adult podocyte progenitors
Rat model ACE-inhibition affects a subset of cells lining Bowman's capsule that coexpress PEC proteins and NCAM (used as a differentiation marker) [28] Diabetic mouse Blockade of the chemokine stromal-derived factor (SFD/ CXCL12) enhanced the differentiation of renal progenitors toward a podocyte phenotype [56] ACE, angiotensin-converting enzyme; NCAM, neural cell adhesion molecule; PEC, parietal epithelial cell. surgically in CoRL reporter mice [79] . As expected, mice developed mild FSGS [79] . However, in a subpopulation of glomeruli that did not have obvious segmental scarring, labeled CoRL could be detected, and a subset of these cells coexpressed several podocyte proteins (Fig. 2 ) [79] . Glomerulosclerosis was substantially reduced in glomeruli with labeled CoRL.
Fifth, we studied the aged mouse kidney, as it is characterized by a progressive segmental and global glomerulosclerosis, accompanied by a slow decline in podocyte number [80] . In CoRL reporter mice aged 1 year, a decrease in podocyte number was accompanied by the presence of CoRL in the intraglomerular compartment, and some of these cells coexpressed podocyte proteins [71] . CoRL in the [8] . A decrease in podocyte number by 20% (represented by the green area) corresponds to a decrease in podocyte number per glomerulus by 112 in man and 14 in mice. A decrease in podocyte number by 21-40% (represented by the yellow area) corresponds to a decrease in podocyte number per glomerulus by 117-224 in man and 15-29 in mice. A decrease in podocyte number by greater than 40% (represented by the red area) corresponds to a decrease in podocyte number per glomerulus by more than 228 in man and more than 30 in mice. A decrease in podocyte number by 20% (represented by the red dashed arrow A) is not accompanied by any serious decline in kidney function, at least over the short term, unless there is subsequent podocyte depletion. In a steady state, we argue therefore that there is no major biological need to replace these podocytes. There is however a need to replace podocytes when their number is depleted between 21 and 40% to limit further synchial formation and focal segmental glomerulosclerosis and to even reverse these processes. However, podocyte replacement does NOT need to return to the normal number for this to happen. Rather, we propose that the goal to replace podocyte number is above the threshold for scarring. As shown in the graph, this is typically less than 20% of normal (represented by the dashed arrow B). For example, to reach 20% of normal from a nadir of 40% of normal to prevent/reverse scarring in an individual glomerulus requires only a 20% increase in podocyte number for that glomerulus (red arrow B). The mean number of glomeruli in a mouse kidney is 12 083 AE 1009 per kidney or 24 166 glomeruli total per mouse [80] . In focal segmental glomerulosclerosis, for example, if 20% of glomeruli are affected, the number of podocytes that need to be replaced in one kidney to return to the original baseline is 67 665 (20% of glomeruli Â 24 166 glomeruli Â 14 podocytes lost per glomerulus). If podocyte number drops by 40% (decrease of 29 podocytes in a single glomerulus), global glomerulosclerosis will ensue. Thus, still using the example of 20% of glomeruli affected implies that 20% of glomeruli Â 24 166 glomeruli Â 29 podocytes lost per glomerulus ¼ 140 162 total podocytes needed. Thus, for repair from a 40% drop in podocytes to a 20% drop in podocytes (above which scarring does not occur), 72 497 podocytes are needed, whereas complete restoration would require 140 162 podocytes. If podocyte number drops below the 40% threshold to 50% for example, then an immediate goal for replacement would be to increase podocyte number by 10% (white arrow C) to limit the progression from focal to global sclerosis and to reverse global to focal sclerosis. The second goal is to increase podocyte number by another 20% to limit focal sclerosis (red arrow B). Finally, several therapies (shown on the right side of the graph) increase podocyte number and in doing so, limit and/or reverse the progression of scarring by regenerative repair (black line) (example is red arrow D), whereas no therapy leads to nonregenerative repair (blue line).
intraglomerular compartment showed characteristic ultramorphological features of podocytes, namely foot processes and slit diaphragms [71] . With increasing age, the density of labeled CoRL within the JGC decreased significantly.
Taken together, in three settings of podocyte depletion (one acute and two chronic), these findings support the notion that CoRL might serve as adult podocyte progenitors and for partial regeneration in states of podocytes depletion (Table 2) .
Evidence not supporting a role for cells of renin lineage as adult glomerular epithelial cell progenitors
As stated above, there is increasing evidence that CoRL have multicellular differentiation potential, that is likely context dependent. One view might be that there are simply too few CoRL to be able to provide any meaningful contribution to podocyte replacement. We therefore believe that multiple progenitors must function to replace podocytes. Moreover, the number of CoRL does increase under certain circumstances such as when mice are given ACE-inhibitors or AT1 blockers, thus providing an increased reservoir size.
WHAT MIGHT BE THE GOALS FOR ADULT PODOCYTE REGENERATION?
Eloquent experimental studies have shown the close correlation between the magnitude of podocyte depletion and the ensuing development of glomerular scarring [8, 9, 81] . How much podocyte replacement is required to recover/repair normal structure and function? We argue that a reasonable goal should be to simply increase podocyte number to that above the critical scarring threshold (20% podocyte loss), which prevents segmental sclerosis progressing to global (Fig. 3) .
CONCLUSION
In conclusion, it is clear that podocyte replacement cells exist in adults. It is now important to investigate more thoroughly whether their enhancement can functionally improve outcomes such as albuminuria. Improved understanding of the mechanisms involved will guide the development of interventions, such as small molecules, that increase the number of podocyte replacement cells above the threshold required to prevent the onset of glomerulosclerosis.
